Thomas Daniel 4
Research Summary
AI-generated summary
Select Medical (SEM) Director Thomas Daniel Sells 80,035 Shares
What Happened
- Thomas Daniel, a director of Select Medical Holdings Corp (SEM), had 80,035 shares disposed to the issuer on 2026-06-30 as part of the company’s merger. The shares were converted into cash at $16.50 per share, for total consideration of $1,320,578. This was a disposition (sale/conversion), not an open-market purchase.
Key Details
- Transaction date and price: 2026-06-30 at $16.50 per share.
- Total proceeds: $1,320,578.
- Transaction type/code: Disposition to issuer (D) — conversion under the merger agreement, not a voluntary market sale.
- Shares owned after transaction: Not specified in the filing; footnotes indicate all outstanding and restricted shares held by the reporting person were converted into the merger consideration (implying no remaining converted shares).
- Footnotes: F1 — conversion per Merger Agreement dated March 2, 2026; F2 — unvested restricted shares vested immediately before the merger and were converted, net of any required tax withholding.
- Filing timeliness: Reported 2026-07-01 for a 2026-06-30 transaction (filed promptly, not flagged late).
Context
- This disposition arose from the company’s merger (each share converted to $16.50 cash). Such merger-related conversions are routine corporate events and don’t necessarily reflect the director’s personal trading intent.